Atlas Trials

A Study to Investigate How JNJ-38518168 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis Participants

Clinical trial NCT01450982 · COMPLETED

Trial details

NCT number
NCT01450982
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2011-06-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.